Paul Aisen, M.D., has conducted therapeutic research on Alzheimer’s disease for the past two decades.
After graduating from Harvard College, Dr. Aisen received his medical degree from the Columbia University College of Physicians and Surgeons in 1979 and pursued his clinical training as a Resident in the Department of Medicine at the University Hospitals of Cleveland, and in the Department of Medicine at the The Mount Sinai Hospital in New York. He completed his Fellowship in the Division of Rheumatology at the New York University Medical Center before returning to The Mount Sinai Hospital as Chief Resident in the Department of Medicine. Dr. Aisen is a diplomate of the American Board of Internal Medicine, with specialty certification in Rheumatology and Geriatric Medicine.
After 15 years on the faculty at Mount Sinai, Dr. Aisen moved to Georgetown University in 1999 as Professor in the Departments of Neurology and Medicine and became Vice Chair of the Department of Neurology in 2004. Since 2007 he has been Professor of Neurosciences at the University of California, San Diego. Dr. Aisen has collaborated extensively with the biotech and pharmaceutical industries for many years. He has led numerous multicenter trials, and has authored over 250 scientific papers. He is Director of the Alzheimer’s Disease Cooperative Study, a consortium funded by the National Institute on Aging to develop assessment instruments and conduct clinical trials.